Symrise invests in research on Xeroderma Pigmentosum

Symrise invests in research on Xeroderma Pigmentosum

  by    0   0

symrise logoSeptember 20, 2013 — Symrise is a German-based cosmetic company.  They announced that they are investing in a three year project with the Research Institute for Environmental Medicine to help find a cure for Xeroderma Pigmentosum ( XP).  Patients with XP suffer from a genetic disorder where the their DNA cannot repair itself from the harmful UVA/UVB radiation.  Minutes in the sun can lead to 3rd degree burns. For many patients can quickly lead to skin cancer.  For more information on XP, please visit the Xeroderma Pigmentosum NIH page.

Symrise awarded the research grant to post-doctorate researcher Marc Majora, PhD.  His previous work with the Research Institute for Environmental Medicine (IUF) focused on photoaging of human skin due to mitochondrial mutations due to UV radiation.  (The study can be found here.)  This study will surely segue him into the current research for XP.

Symrise is known for cosmetic UV Filters used in many commercial cosmetic products that are widely used today.

Symrise Webcast

A webcast on the Symrse website will be held on September 26, 2013.  They aim to reveal the collaboration goals and give a better understanding of Xeroderma Pigmentosum.

The future of Xeroderma Pigmentosum studies

This bold move from a cosmetic company to aid in finding a cure for Xeroderma Pigmentosum is huge.  Although Symrise is most likely looking at XP to find a beauty product for anti-aging properties, it is a huge step in broadening the spectrum in finding a cure.  Currently, studies for XP are largely government-based.  This move is a small nod to the world that Symrise understands that finding a cure for XP can lead to finding a cure for skin cancer in general.  Currently, XP patients must wear plastic hoods and other protective clothing to protect themselves from the harmful UV rays.  Ultimately, knowing how to fit the genetic pieces together in an XP patient can help in creating a product that could someday help remove the plastic barrier.

Michele Milota, the Executive Director of XP Family Support Group says that “any research on XP is good research.  Bringing Xeroderma Pigmentosum out to the public light gives us a chance to educate them on XP.”

For the full story on Symrise’s part in finding a cure to XP, please read Michelle Yeomanns’ article that appeared in CosmeticsDesign.com

 

RELATED POSTS

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: